Sort
30,917 grants matching “tumor microenvironment”
Cellular Responses to Vitronectin Binding Integrins
$335,231David A Cheresh · University Of California, San Diego · R01 · FY2006 · CA
Project 4: Awakening immune responses to GBM by enhancing immune cell trafficking and activation with oHSV armed with Cetuximab-CCL5 and anti-CD47 antibody payloads.
$335,203Michael A Caligiuri · Brigham And Women'S Hospital · P01 · FY2025 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$335,170Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · CA
Alternative NF-kB in Bone Microenvironment
$335,160Deborah V Novack · Washington University · R01 · FY2014 · AR
Tumor and Stromal Metalloproteinases in Breast Cancer
$335,128Barbara Fingleton · Vanderbilt University · R01 · FY2014 · CA
Mechanism of double-negative T cells in antitumor immunity to breast cancer
$335,119Hui Zhang · Washington State University · R01 · FY2024 · CA
Optical platform for functional longitudinal imaging of metabolite uptake in vivo
$335,116Elena Goun · University Of Missouri-Columbia · R01 · FY2024 · EB
Role of the extracellular matrix during Wolffian/epididymal duct morphogenesis
$335,113Barry T. Hinton · University Of Virginia · R01 · FY2018 · HD
Gut microbiota and inflammatory monocytes in colorectal cancer
$335,113Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2012 · CA
Gut microbiota and inflammatory monocytes in colorectal cancer
$335,113Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2015 · CA
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$335,113Qing Yi · Methodist Hospital Research Institute · R01 · FY2021 · CA
Role of the extracellular matrix during Wolffian/epididymal duct morphogenesis
$335,113Barry T. Hinton · University Of Virginia · R01 · FY2019 · HD
Role of the extracellular matrix during Wolffian/epididymal duct morphogenesis
$335,113Barry T. Hinton · University Of Virginia · R01 · FY2020 · HD
A novel NKG2D-specific BiTE cancer immunotherapy
$335,113Charles L Sentman · Dartmouth College · R01 · FY2013 · CA
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$335,113Qing Yi · Methodist Hospital Research Institute · R01 · FY2020 · CA
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
$335,096Michael C Bassik · Stanford University · U54 · FY2024 · CA
Biology Core
$335,055Meenhard Herlyn · Wistar Institute · P01 · FY2021 · CA
MAPK pathway modulation in thyroid tumorigenesis
$335,050Aime T. Franco · Univ Of Arkansas For Med Scis · R01 · FY2019 · CA
Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma
$335,040Fernando Anthony Ferrer · University Of Connecticut Sch Of Med/Dnt · R01 · FY2014 · CA
Project 2- Liquid Biopsies for Melanoma that Metastasizes to Inaccessible Sites
$335,000David A. Hafler · Yale University · P50 · FY2018 · CA
Functional Imaging of Twist induced breast cancer
$334,988Venu Raman · Johns Hopkins University · R01 · FY2010 · CA
Platinum-induced lipid reprogramming and tumor immune microenvironment in SCLC
$334,978Lingtao Jin · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors
$334,967Karen M Cichowski · Brigham And Women'S Hospital · U01 · FY2024 · CA
Neuroimmunomodulation within the eye
$334,940Andrew W Taylor · Schepens Eye Research Institute · R01 · FY2006 · EY
Core Support for Cancer Center
$334,913Edward Chu · Albert Einstein College Of Medicine · P30 · FY2022 · CA